Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slove-nian real-world data. (2026). Radiology and Oncology, 60(2), 288-293. https://www.radioloncol.com/index.php/ro/article/view/4731